Evidence map›Paper›PMID 40604877›Full record

ArticleOrphanet journal of rare diseases2025

Development of the accredited duchenne centers program, a global program to achieve uniform and up-to-date care for all people living with duchenne muscular dystrophy.

Imelda J M de Groot, Karolina Podolská, Nathalie Goemans, Suzie-Ann Bakker, Nawel Lalout, Merel Jansen, Elizabeth Vroom

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Duchenne Muscular Dystrophy Under Three Years of Age.Children (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Imelda J M de GrootWorld Duchenne Organization, Landjuweel 34, 3905 PG, Veenendaal, The Netherlands. imelda.degroot@worldduchenne.org.
Karolina PodolskáWorld Duchenne Organization, Landjuweel 34, 3905 PG, Veenendaal, The Netherlands.
Nathalie GoemansAccredited Duchenne Centers Advisory Board, Veenendaal, The Netherlands.
Suzie-Ann BakkerWorld Duchenne Organization, Landjuweel 34, 3905 PG, Veenendaal, The Netherlands.
Nawel LaloutDuchenne Parent Project, Veenendaal, The Netherlands.
Merel JansenWorld Duchenne Organization, Landjuweel 34, 3905 PG, Veenendaal, The Netherlands.
Elizabeth VroomWorld Duchenne Organization, Landjuweel 34, 3905 PG, Veenendaal, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Accredited Duchenne Centers (ADC) Program is a global program initiated by the World Duchenne Organization (WDO). The aim of the ADC Program is to achieve global, uniform and up-to-date care for all people living with Duchenne Muscular Dystrophy (DMD) that are in line with the latest international care considerations and care guidelines. This will be realized by accrediting Duchenne care centers for children and/or adults that provide comprehensive care according to the latest care considerations, and supporting care centers that do not yet meet these criteria for accreditation, to improve care provided to DMD patients. The accreditation process consists of five stages ranging from application to maintenance of accreditation by continuous education. The accreditation criteria and procedures were developed in close collaboration with an international Advisory Board. This paper describes the development and content of the ADC Program. The ADC Program is the first global accreditation program for both children and adults with DMD. The results of the program may contribute to optimal implementation of the latest research insights and optimum care for all people living with DMD and their families.

Indexed as

AccreditationMuscular Dystrophy, DuchenneAdultChildHumansAccredited duchenne centers (ADC) programCare considerationsCertificationConsensus guidelinesDuchenne muscular dystrophyGlobal

Identifiers

PMID40604877
PMCPMC12224344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.